Back to Journals » OncoTargets and Therapy » Volume 11
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage [Corrigendum]
Liu WJ, Yin YB, Sun JY, et al. Onco Targets Ther. 2018; 11:5429–5439.
The authors have advised that a number of corrections need to be made.
Read the original article.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.